Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 20281 AL 20295

The shift to a proteinopenia paradigm in neurodegeneration

Ezzat K, Sturchio A, Espay AJ.

Handb Clin Neurol. 2023;193:23-32. doi: 10.1016/B978-0-323-85555-6.00001-1.

Neurons, Nose, and Neurodegenerative Diseases: Olfactory Function and Cognitive Impairment

Fatuzzo I, Niccolini GF, Zoccali F, Cavalcanti L, Bellizzi MG, Riccardi G, de Vincentiis M, Fiore M, Petrella C, Minni A, Barbato C.

Int J Mol Sci. 2023 Jan 20;24(3):2117. doi: 10.3390/ijms24032117.

Substance abuse and neurodegenerative diseases: focus on ferroptosis

Guo C, Chen L, Wang Y.

Arch Toxicol. 2023 Jun;97(6):1519-1528. doi: 10.1007/s00204-023-03505-4. Epub 2023 Apr 26.

Use of cannabidiol (CBD) for the treatment of cognitive impairment in psychiatric and neurological illness: A narrative review

Ortiz R, Rueda S, Di Ciano P.

Exp Clin Psychopharmacol. 2023 Oct;31(5):978-988. doi: 10.1037/pha0000659. Epub 2023 May 1.

Biosensors, Recent Advances in Determination of BDNF and NfL

Mobed A, Charsouei S, Yazdani Y, Gargari MK, Ahmadalipour A, Sadremousavi SR, Farrahizadeh M, Shahbazi A, Haghani M.

Cell Mol Neurobiol. 2023 Nov;43(8):3801-3814. doi: 10.1007/s10571-023-01401-0. Epub 2023 Aug 21.

Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review

Singh K, Bhushan B, Chanchal DK, Sharma SK, Rani K, Yadav MK, Porwal P, Kumar S, Sharma A, Virmani T, Kumar G, Noman AA.

Behav Neurol. 2023 Oct 12;2023:8825358. doi: 10.1155/2023/8825358. eCollection 2023.

Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders

Zheng Y, Bonfili L, Wei T, Eleuteri AM.

Nutrients. 2023 Oct 31;15(21):4631. doi: 10.3390/nu15214631.

Task-Evoked Pupillary Response as a Potential Biomarker of Dementia and Mild Cognitive Impairment: A Scoping Review

Zeeman M, Figeys M, Brimmo T, Burnstad C, Hao J, Kim ES.

Am J Alzheimers Dis Other Demen. 2023 Jan-Dec;38:15333175231160010. doi: 10.1177/15333175231160010.

Insulin and disorders of behavioural flexibility

Sullivan M, Fernandez-Aranda F, Camacho-Barcia L, Harkin A, Macrì S, Mora-Maltas B, Jiménez-Murcia S, O'Leary A, Ottomana AM, Presta M, Slattery D, Scholtz S, Glennon JC.

Neurosci Biobehav Rev. 2023 Jul;150:105169. doi: 10.1016/j.neubiorev.2023.105169. Epub 2023 Apr 12.

Research progress of plant-derived natural alkaloids in central nervous system diseases

Zhang Q, Jiang Q, Sa K, Liang J, Sun D, Li H, Chen L.

Phytother Res. 2023 Nov;37(11):4885-4907. doi: 10.1002/ptr.7955. Epub 2023 Jul 16.

Speech and language markers of neurodegeneration: a call for global equity

García AM, de Leon J, Tee BL, Blasi DE, Gorno-Tempini ML.

Brain. 2023 Dec 1;146(12):4870-4879. doi: 10.1093/brain/awad253.

Cholinesterase Inhibitors for Treatment of Psychotic Symptoms in Alzheimer Disease and Parkinson Disease: A Meta-analysis

d'Angremont E, Begemann MJH, van Laar T, Sommer IEC.

JAMA Neurol. 2023 Aug 1;80(8):813-823. doi: 10.1001/jamaneurol.2023.1835.

Circadian rhythms in the blood-brain barrier: impact on neurological disorders and stress responses

Schurhoff N, Toborek M.

Mol Brain. 2023 Jan 12;16(1):5. doi: 10.1186/s13041-023-00997-0.

Melatonin Can Modulate Neurodegenerative Diseases by Regulating Endoplasmic Reticulum Stress

Yoo YM, Joo SS.

Int J Mol Sci. 2023 Jan 25;24(3):2381. doi: 10.3390/ijms24032381.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias